Arterial Switch Operation in India and UAE | Complete Patient Guide

• IDEAL SURGICAL CANDIDATES:

• Neonates (ideally aged 5–21 days) with confirmed TGA with intact ventricular septum (TGA-IVS), where the left ventricle is still primed for systemic work

• Infants with TGA and Ventricular Septal Defect (TGA-VSD), where the VSD maintains left ventricular pressure and allows a wider surgical window (up to 4–6 weeks or beyond, depending on pulmonary vascular resistance)

• Neonates with Taussig-Bing anomaly (double-outlet right ventricle with subpulmonary VSD), which is physiologically and surgically managed as TGA-VSD

• Patients with TGA and left ventricular outflow tract obstruction (LVOTO), where the Nikaidoh procedure (aortic root translocation) or Réparation à l'Étage Ventriculaire (REV procedure) may be preferred over classic ASO

• Older infants with TGA-IVS who have undergone successful two-stage preparation (PA banding + BT shunt) to retrain the left ventricle for systemic pressures

• REQUIRED DIAGNOSTIC EVALUATION BEFORE ASO:

• Comprehensive neonatal transthoracic echocardiography (TTE): defines great artery relationships, coronary artery anatomy and course, VSD location and size, arch anatomy, and ventricular function — the single most critical pre-operative imaging study

• Coronary artery mapping: echocardiographic identification of coronary ostia using a validated classification system (e.g., Leiden classification or Yacoub/Radley-Smith system) to anticipate transfer technique; CT angiography (low-dose, gated) for intramural or ambiguous coronary patterns

• Arterial blood gas (ABG) and pulse oximetry: to quantify cyanosis severity and guide urgency

• Chest X-ray: classic 'egg-on-a-string' cardiac silhouette with narrow mediastinum

• Complete blood count, metabolic panel, coagulation profile, and blood typing for intra-operative transfusion planning

• Balloon atrial septostomy (Rashkind procedure): performed as a therapeutic intervention under echocardiographic guidance (or fluoroscopy) to improve atrial-level mixing and oxygen saturation pre-operatively

• Brain MRI or cranial ultrasound: to rule out pre-existing hypoxic-ischemic injury that could influence peri-operative management and neurodevelopmental prognosis

• Prostaglandin E1 (PGE1) level and ductal patency confirmation

• RELATIVE CONTRAINDICATIONS AND HIGH-RISK FEATURES:

• Significant left ventricular dysfunction or left ventricular mass index below threshold for systemic work (in late-presenting TGA-IVS without prior PA banding)

• Severe, irreversible pulmonary hypertension with fixed elevated pulmonary vascular resistance (rare in TGA but possible in TGA-VSD with delayed presentation)

• Complex intramural coronary anatomy with high predicted coronary transfer risk — requires a surgeon with specific experience; not a contraindication but a significant risk modifier

• Associated major non-cardiac anomalies (e.g., severe DiGeorge syndrome, major chromosomal abnormality) that alter the risk-benefit analysis

• Pre-operative multi-organ dysfunction secondary to prolonged severe cyanosis or sepsis — requires stabilization before surgical candidacy is confirmed

• Severe prematurity or very low birth weight (<2 kg) — increases cardiopulmonary bypass risk; timing must be individualized

STANDARD ARTERIAL SWITCH OPERATION (ASO) — THE JATENE PROCEDURE:

The classic ASO is performed through a median sternotomy under cardiopulmonary bypass (CPB) with moderate hypothermia (typically 18–25°C, with deep hypothermic circulatory arrest (DHCA) at 18°C used selectively for arch work or complex coronary transfers in some centers). The operative sequence includes: (1) establishment of CPB via aortic and bicaval cannulation; (2) transection of the aorta and pulmonary artery above the semilunar valves; (3) coronary artery transfer — buttons of aortic wall surrounding each coronary ostium are excised and reimplanted into the posterior great vessel (neopulmonary root, which becomes the neoaorta); (4) the LeCompte maneuver, in which the distal pulmonary artery is brought anterior to the reconstructed aorta to avoid tension on the pulmonary bifurcation; (5) great artery reconstruction with direct anastomosis or pericardial patch augmentation; (6) VSD closure (if present) through the right ventriculotomy or transatrial approach; and (7) cardiac de-airing and separation from CPB with transesophageal echocardiography (TEE) confirmation of biventricular function and coronary perfusion. Myocardial protection employs cold blood cardioplegia (del Nido cardioplegia solution is widely favored in pediatric cardiac surgery for its prolonged arrest quality and reduced re-dosing requirements), supplemented by topical cooling.

CORONARY TRANSFER TECHNIQUES — THE CRITICAL VARIABLE:

Coronary artery transfer is the step most predictive of mortality and morbidity. In standard coronary anatomy (Type A, Leiden 1RCx;2L — right coronary from sinus 1, circumflex and left anterior descending from sinus 2), a straightforward 'trap door' or 'button' transfer is performed. Complex patterns — including intramural courses (coronary traveling within the aortic wall, requiring unroofing), single coronary ostium, inverted coronaries, or posterior circumflex origin — require surgeon-specific expertise and may employ techniques such as the trapdoor flap, the pedicle transfer, the intramural unroofing technique, or coronary routing using pericardial tunnels. High-volume centers with documented experience in ≥5 complex coronary pattern subtypes demonstrate significantly superior outcomes for these variants.

TWO-STAGE ASO FOR LATE-PRESENTING TGA-IVS:

For neonates or infants presenting after the left ventricular regression window (typically beyond 3–4 weeks in TGA-IVS), the left ventricle may be inadequately prepared to assume systemic workload. In these patients, a two-stage strategy is employed: Stage 1 involves pulmonary artery banding (to impose pressure load on the LV) combined with a systemic-to-pulmonary shunt (modified Blalock-Taussig-Thomas shunt) to maintain oxygenation. Left ventricular mass index is monitored by echocardiography; once adequate retraining is achieved (typically within 1–2 weeks in neonates, longer in older infants), Stage 2 ASO is performed. This approach carries higher combined procedural risk than primary ASO but remains the best strategy for selected patients.

ALTERNATIVE ANATOMIC REPAIRS FOR COMPLEX TGA VARIANTS:

• Nikaidoh Procedure (Aortic Root Translocation): Preferred for TGA-VSD with significant LVOTO (subpulmonary obstruction). The aortic root, including the coronary arteries, is translocated posteriorly onto the left ventricular outflow tract, combined with VSD closure and right ventricular outflow tract reconstruction using a homograft or conduit. Avoids the long-term risk of RVOT reintervention common with the REV procedure's direct RVOT-to-PA anastomosis.

• REV Procedure (Réparation à l'Étage Ventriculaire): An alternative for TGA-VSD-LVOTO employing intra-ventricular tunneling, pulmonary root translocation, and direct RVOT-to-pulmonary artery anastomosis (Lecompte maneuver) without an external conduit, reducing the need for conduit replacement but with a risk of late branch pulmonary artery stenosis.

• Atrial-Level Repair (Historical — Mustard/Senning): Now largely abandoned for primary repair of TGA due to well-documented long-term risks of systemic right ventricular failure, baffle obstruction, and atrial arrhythmias. However, these patients (now adults) may present for late surgical or catheter-based interventions such as baffle stenting, pulmonary venous baffle dilatation, or cardiac resynchronization therapy — services available at GAF Healthcare partner centers.

INTERVENTIONAL AND HYBRID APPROACHES:

• Balloon Atrial Septostomy (BAS/Rashkind): A catheter-based palliative procedure (not a repair) performed emergently in cyanotic neonates prior to definitive surgery to improve inter-atrial mixing. Performed in the cardiac catheterization laboratory or at the bedside under echocardiographic guidance.

• Transcatheter Pulmonary Valve Replacement (TPVR/Melody/Edwards SAPIEN): Relevant for post-ASO long-term follow-up, where patients may develop neopulmonary valve regurgitation or branch pulmonary artery stenosis decades after ASO; transcatheter valve-in-conduit procedures can defer or replace surgical reintervention.

• Intraoperative Neuromonitoring: Near-infrared spectroscopy (NIRS) for cerebral and somatic oximetry monitoring during CPB and DHCA is standard at leading pediatric cardiac centers, minimizing neurodevelopmental injury — a critical quality metric for families.

POST-OPERATIVE HEMODYNAMIC MANAGEMENT IN THE PICU:

ASO survivors are managed with targeted hemodynamic protocols including milrinone (a phosphodiesterase-3 inhibitor for biventricular support and pulmonary vasodilation), dopamine or epinephrine for inotropy, nitric oxide (iNO) for pulmonary hypertensive crises, and strict fluid balance management. Delayed sternal closure is employed in patients with post-bypass myocardial edema. Neurodevelopmental follow-up is a standard component of long-term care at high-quality centers.

PHASE 1 — PRE-OPERATIVE REFERRAL AND EVALUATION (Days 1–3 after GAF Healthcare Engagement): Upon receiving the patient's records (echocardiogram, clinical notes, birth history) through GAF Healthcare's secure portal, the partner hospital's pediatric congenital cardiac surgery team conducts a formal case review within 24–48 hours. A written surgical opinion, estimated cost, and proposed admission date are provided. GAF Healthcare simultaneously initiates Indian e-Medical Visa or UAE entry visa processing for the parents/guardians. Upon arrival, the neonate or infant is admitted to the Pediatric Cardiac ICU for immediate stabilization: prostaglandin E1 (PGE1) infusion is commenced or continued to maintain ductal patency; blood gases, electrolytes, and hemoglobin are optimized; and a formal pre-operative echocardiogram is performed by the institutional pediatric cardiologist to confirm coronary anatomy and surgical planning. Balloon atrial septostomy (BAS) is performed if inter-atrial mixing is inadequate. Cardiac anesthesia consultation, pre-operative blood cross-matching, and consent discussions with the surgical team are completed.

PHASE 2 — SURGICAL DAY (Day 3–5 Post-Admission, or Urgently as Indicated): The ASO typically requires 4–7 hours of total operative time. The neonate is taken to a dedicated pediatric cardiac operating theater. General anesthesia is induced and maintained by a specialist pediatric cardiac anesthesiologist. Continuous intraoperative monitoring includes arterial line (radial or umbilical), central venous line, transesophageal echocardiography (TEE), NIRS cerebral oximetry, and temperature probes. Cardiopulmonary bypass is established, myocardial arrest achieved with del Nido cardioplegia, and the arterial switch procedure is executed as described. Following successful coronary reimplantation and great artery reconstruction, the heart is rewarmed, deaired, and weaned from bypass under TEE guidance confirming biventricular function and coronary perfusion. The sternum is closed primarily or left open (delayed closure in 24–48 hours) based on hemodynamic stability. Total CPB time ranges from 90–180 minutes; aortic cross-clamp time 60–120 minutes depending on complexity.

PHASE 3 — PEDIATRIC CARDIAC ICU (Days 1–10 Post-Surgery): The neonate is mechanically ventilated initially and weaned progressively as cardiac function improves. Hemodynamic support with vasoactive agents (milrinone, epinephrine, dopamine) is titrated by the pediatric cardiac intensivist. Inhaled nitric oxide (iNO) is available for pulmonary hypertensive episodes. Daily echocardiograms assess ventricular function, coronary perfusion, and valve competence in the first 48–72 hours. Surgical wounds are monitored, and sternal closure (if delayed) is performed in the OR under general anesthesia. Extubation is targeted at 24–72 hours in uncomplicated cases. Enteral feeding is initiated and advanced as tolerated. Parents receive daily structured updates from the surgical and ICU team, with GAF Healthcare's patient coordinator present as interpreter and liaison.

PHASE 4 — STEP-DOWN WARD (Days 10–18 Post-Surgery): Following PICU discharge, the infant is monitored on the pediatric cardiology ward. Oral cardiac medications are consolidated (typically aspirin for 6 months for coronary protection post-ASO; diuretics as needed; prophylactic antibiotics per institutional protocol). Parents are trained in wound care, medication administration, feeding techniques, and recognition of warning signs (fever, cyanosis, respiratory distress, poor feeding). A pre-discharge echocardiogram, chest X-ray, and ECG are performed. Surgical follow-up appointments and a cardiac clearance report for air travel are prepared by the surgical team.

PHASE 5 — RECOVERY AND FIT-TO-FLY ASSESSMENT (Weeks 3–8): The infant remains in-country for a minimum of 2 weeks post-discharge in a GAF Healthcare partner accommodation near the hospital, enabling outpatient follow-up visits at weeks 3, 4, and 6 post-surgery. Fit-to-fly clearance is typically granted at 6–8 weeks post-surgery when the following milestones are confirmed: stable hemodynamics on echocardiography, healed sternotomy wound, adequate weight gain and feeding, no residual hemodynamically significant lesions, and oxygen saturation >92% on room air. For long-haul international flights (>6 hours), a detailed medical summary, in-flight oxygen prescription (if needed), and contact protocols are provided. A pediatric cardiologist in the home country is identified in advance through GAF Healthcare's international care coordination network for seamless handover.